Fullerene derivatives as inhibitors of the SARS-CoV-2 main protease

Daiki Katagishi1, Daisuke Yasuda1, Kyoko Takahashi2

  • 1Department of Pharmaceutical Sciences, Faculty of Pharmacy, Keio University, 1-5-30 Shibakoen, Minato-ku, Tokyo, Japan.